Epidemiological report on the treatment of patients with gestational trophoblastic disease in 10 Brazilian referral centers: Results after 12 years since international FIGO 2000 consensus

Nenhuma Miniatura disponível

Data

2014-06-01

Autores

Braga, Antonio [UNESP]
Uberti, Elza Maria Hartmann [UNESP]
Fajardo, Maria do Carmo [UNESP]
Viggiano, Maurício [UNESP]
Sun, Sue Yazaki [UNESP]
Grillo, Bruno Maurizio [UNESP]
Padilha, Sérgio Lunardon [UNESP]
de Andrade, Jurandyr Moreira [UNESP]
de Souza, Christiani Bisinoto [UNESP]
Madi, José Mauro [UNESP]

Título da Revista

ISSN da Revista

Título de Volume

Editor

Resumo

OBJECTIVE: To evaluate treatment of Brazilian patients with gestational trophoblastic disease (GTD). STUDY DESIGN: A retrospective cohort study with analysis of medical reports performed in 10 Brazilian referral centers from January 2000 to December 2011. RESULTS: Of 5,250 patients 3 died (0.06%) at the time of uterine evacuation. Spontaneous remission of GTD (group G1) was observed in 4,103 cases, and 1,144 (21.8%) progressed to gestational trophoblastic neoplasia (GTN) (G2). In G1 2,716 (66.2%) had complete hydatidiform mole (HM) and 1,210, partial HM (29.5%); 3,772 patients (92.7%) recovered as noted in December 2012. In G2, of 1,118 patients treated, initial histopathological results of previous gestation were complete HM (77.5% [n=886]), partial HM (8.8% [n= 100]), and choriocarcinoma (8.0% [n=92]); 930 (81.3%) were low-risk, 200 (17.5%) were high-risk GTN, and 14 had placental site trophoblastic tumor (PSTT) (1.2%); cure was achieved in 1,078 cases (96.4%), but 26 patients (2.3%) died (4 lowrisk [0.4%], 19 high-risk [9.5%], and 3 PSTT [21.4%]). CONCLUSION: The highest death rates were due to high-risk GTN and PSTT. Patients with molar pregnancy should be referred to a referral center for an early diagnosis and prompt treatment of GTN in order to reduce the morbidity and mortality found in advanced stages.

Descrição

Palavras-chave

Epidemiology, Gestational trophoblastic disease, Gestational trophoblastic neoplasia, Hydatidiform mole, Placental site trophoblastic tumor

Como citar

Journal of Reproductive Medicine, v. 59, n. 3, p. 241-247, 2014.